Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 11.429\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a) CCC(C)[C@H](NC(=O)N1CCC(Cc2ccccc2)CC1)C(=O)O
b) Nc1nnn(CC(=O)N/N=C/c2ccncc2)n1
c) COc1ccc(Br)cc1CN1CCN(C(=O)c2cccc(OC)c2OC)CC1.O=C(O)C(=O)O
d) O=C(O)c1ccccc1Nc1ccccc1C(=O)O
Answer: b. Nc1nnn(CC(=O)N/N=C/c2ccncc2)n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Nc1nnn(CC(=O)N/N=C/c2ccncc2)n1
Nc1nnn(CC(=O)N/N=C/c2ccncc2)n1
2-(5-aminotetrazol-2-yl)-N-[(E)-pyridin-4-ylmethylideneamino]acetamide